蛋白尿
糖尿病肾病
疾病
糖尿病
终末期肾病
肾功能
相伴的
肾病
肾脏疾病
心脏病学
内科学
医学
重症监护医学
内分泌学
作者
Manpreet K. Sagoo,Luigi Gnudi
出处
期刊:Methods in molecular biology
日期:2019-11-07
卷期号:: 3-7
被引量:256
标识
DOI:10.1007/978-1-4939-9841-8_1
摘要
Diabetic nephropathy (DN) is one of the most feared diabetic chronic microvascular complications and the major cause of end-stage renal disease (ESRD). The classical presentation of DN is characterized by hyperfiltration and albuminuria in the early phases which is then followed by a progressive renal function decline. The presentation of diabetic kidney disease (DKD) can vary especially in patients with T2DM where concomitant presence of other glomerular/tubular pathologies and severe peripheral vascular disease can become important confounders. All-cause mortality in individuals with DKD is approximately 30 times higher than that in diabetic patients without nephropathy and a great majority of patients with DKD will die from cardiovascular disease before they reach ESRD. The management of metabolic and hemodynamic perturbations for the prevention and for the delay of progression of DKD is very important. DKD is a global challenge and a significant social and economic burden; research should aim at developing new ideas to tackle this devastating condition.
科研通智能强力驱动
Strongly Powered by AbleSci AI